15.66
price up icon0.90%   0.14
 
loading

Inhibrx Biosciences Inc 주식(INBX)의 최신 뉴스

pulisher
Sep 25, 2024

How To Trade (INBX) - Stock Traders Daily

Sep 25, 2024
pulisher
Sep 19, 2024

why ImmunityBio Inc [IBRX] is a Good Choice for Investors After New Price Target of $6.38 - The DBT News

Sep 19, 2024
pulisher
Sep 19, 2024

INVX underperforms with a -2.86 decrease in share price - US Post News

Sep 19, 2024
pulisher
Sep 19, 2024

You might want to take a look at Imunon Inc (IMNN) now - SETE News

Sep 19, 2024
pulisher
Sep 19, 2024

Immuneering Corp [IMRX] Shares Fall Approximately -71.25% Over the Year - Knox Daily

Sep 19, 2024
pulisher
Sep 19, 2024

ImmunityBio, Inc. (NASDAQ:IBRX) Shares Purchased by Private Advisor Group LLC - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Incyte (NASDAQ:INCY) Given “Hold” Rating at Truist Financial - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Inhibrx, Inc. (NASDAQ:INBX) Short Interest Down 6.9% in August - Defense World

Sep 19, 2024
pulisher
Sep 18, 2024

InnovAge (NASDAQ:INNV) Trading Up 4.2% - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

William Hoffman Sells 40,000 Shares of Inari Medical, Inc. (NASDAQ:NARI) Stock - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

INmune Bio, Inc. (NASDAQ:INMB) Sees Large Increase in Short Interest - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

INmune Bio stock remains a Buy with positive data correlation in Alzheimer’s study, says Scotiabank - Investing.com

Sep 18, 2024
pulisher
Sep 18, 2024

A review of IMNN’s current quarter earnings predictions - US Post News

Sep 18, 2024
pulisher
Sep 18, 2024

Its Stock Has Paid Off Big Time For INmune Bio Inc - SETE News

Sep 18, 2024
pulisher
Sep 18, 2024

Inhibrx, Inc. (NASDAQ:INBX) Short Interest Update - MarketBeat

Sep 18, 2024
pulisher
Sep 18, 2024

IBRX Stock on the Rise: A Promising Investment - The InvestChronicle

Sep 18, 2024
pulisher
Sep 18, 2024

Market Watch: Immuneering Corp (IMRX)’s Noteworthy Drop, Closing at 2.78 - The Dwinnex

Sep 18, 2024
pulisher
Sep 18, 2024

Truist downgrades Incyte to "hold" on doubts of near-term prospects - XM

Sep 18, 2024
pulisher
Sep 18, 2024

Incyte (NASDAQ:INCY) Receives Market Perform Rating from JMP Securities - Defense World

Sep 18, 2024
pulisher
Sep 18, 2024

Imunon (NASDAQ:IMNN) Shares Up 5.6% - Defense World

Sep 18, 2024
pulisher
Sep 17, 2024

Ratio Review: Analyzing Innovex International Inc. (INVX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Sep 17, 2024
pulisher
Sep 17, 2024

10% Owner Of Impinj Makes $20.00M Buy - Benzinga

Sep 17, 2024
pulisher
Sep 16, 2024

Inmune Bio CFO acquires $49k in company stock By Investing.com - Investing.com Canada

Sep 16, 2024
pulisher
Sep 16, 2024

Inmune Bio CEO acquires $98k in company stock - Investing.com

Sep 16, 2024
pulisher
Sep 16, 2024

Inmune Bio CFO buys $49k in company stock - Investing.com

Sep 16, 2024
pulisher
Sep 16, 2024

Inhibrx CEO buys shares worth over $629k - Investing.com India

Sep 16, 2024
pulisher
Sep 16, 2024

Inhibrx CEO buys shares worth over $629k By Investing.com - Investing.com Canada

Sep 16, 2024
pulisher
Sep 16, 2024

Inhibrx CEO buys shares worth over $629k - Investing.com

Sep 16, 2024
pulisher
Sep 16, 2024

Incyte Corp. stock outperforms competitors on strong trading day - MarketWatch

Sep 16, 2024
pulisher
Sep 16, 2024

Inhibrx CEO buys shares worth over $629k By Investing.com - Investing.com UK

Sep 16, 2024
pulisher
Sep 16, 2024

How will ImmunityBio Inc’s (IBRX) earnings compare to estimates this quarter? - US Post News

Sep 16, 2024
pulisher
Sep 16, 2024

What is IMRX’s price-to-sales ratio telling us about the company’s value? - US Post News

Sep 16, 2024
pulisher
Sep 16, 2024

Impinj 10% Owner Trades $20.00M In Company Stock - Benzinga

Sep 16, 2024
pulisher
Sep 16, 2024

Take off with ImmunityBio Inc (IBRX): Get ready for trading - SETE News

Sep 16, 2024
pulisher
Sep 16, 2024

SEC Form 424B5 filed by INmune Bio Inc. - Quantisnow

Sep 16, 2024
pulisher
Sep 16, 2024

Financial Metrics Check: ImmunityBio Inc (IBRX)’s Ratios for Trailing Twelve Months - The Dwinnex

Sep 16, 2024
pulisher
Sep 16, 2024

IMRX Stock Soars on Upbeat Efficacy Data From Pancreatic Cancer Study - Yahoo Finance

Sep 16, 2024
pulisher
Sep 16, 2024

What is Immuneering Corp (IMRX) Stock Return on Shareholders’ Capital? - SETE News

Sep 16, 2024
pulisher
Sep 16, 2024

IMRX stock rated a Buy by Needham - Knox Daily

Sep 16, 2024
pulisher
Sep 16, 2024

Immuneering’s (IMRX) Buy Rating Reiterated at Needham & Company LLC - Defense World

Sep 16, 2024
pulisher
Sep 15, 2024

Inhibrx: The Biotech Spinoff Poised For Big Gains - Forbes

Sep 15, 2024
pulisher
Sep 15, 2024

(INBX) Long Term Investment Analysis - Stock Traders Daily

Sep 15, 2024
pulisher
Sep 13, 2024

INmune Bio stock dips on $13M securities offering - MSN

Sep 13, 2024
pulisher
Sep 13, 2024

Inhibrx Biosciences director buys shares worth nearly $100k - Investing.com

Sep 13, 2024
pulisher
Sep 13, 2024

Inhibrx Biosciences director buys shares worth nearly $100k By Investing.com - Investing.com Canada

Sep 13, 2024
pulisher
Sep 13, 2024

Director Kristiina Vuori Purchases Shares of Inhibrx Biosciences Inc (INBX) By GuruFocus - Investing.com Canada

Sep 13, 2024
pulisher
Sep 12, 2024

Inhibrx Biosciences director buys shares worth nearly $100k By Investing.com - Investing.com UK

Sep 12, 2024
pulisher
Sep 04, 2024

Inhibrx director Kristiina Vuori buys $99,960 in company stock By Investing.com - Investing.com Australia

Sep 04, 2024
pulisher
Sep 03, 2024

Inhibrx CEO Mark Lappe buys $596,762 worth of company stock - Investing.com

Sep 03, 2024
pulisher
Sep 03, 2024

Inhibrx director Kristiina Vuori buys $99,960 in company stock - Investing.com

Sep 03, 2024
pulisher
Sep 03, 2024

Inhibrx CEO Mark Lappe buys $596,762 worth of company stock - Investing.com India

Sep 03, 2024
pulisher
Sep 03, 2024

Inhibrx CEO Mark Lappe buys $596,762 worth of company stock By Investing.com - Investing.com Canada

Sep 03, 2024
pulisher
Sep 03, 2024

Inhibrx director Kristiina Vuori buys $99,960 in company stock - Investing.com India

Sep 03, 2024
pulisher
Sep 03, 2024

Inhibrx director Kristiina Vuori buys $99,960 in company stock By Investing.com - Investing.com Canada

Sep 03, 2024
pulisher
Sep 03, 2024

Around $2M Bet On Franklin Resources? Check Out These 4 Stocks Executives Are Buying - Benzinga

Sep 03, 2024
pulisher
Aug 31, 2024

Inhibrx biosciences director Kimberly Manhard buys $139,800 in stock - Investing.com India

Aug 31, 2024
pulisher
Aug 30, 2024

Inhibrx biosciences director Kimberly Manhard buys $139,800 in stock - Investing.com

Aug 30, 2024
pulisher
Aug 30, 2024

Inhibrx biosciences director Kimberly Manhard buys $139,800 in stock By Investing.com - Investing.com South Africa

Aug 30, 2024
pulisher
Aug 30, 2024

Where are the Opportunities in (INBX) - Stock Traders Daily

Aug 30, 2024
pulisher
Aug 25, 2024

Inhibrx gains after insider purchases from CEO - MSN

Aug 25, 2024
pulisher
Aug 23, 2024

Hedge Fund and Insider Trading News: Boaz Weinstein, Bill Ackman, Third Point, AQR Capital Management, Inhibrx Biosciences Inc (INBX), Comstock Resources Inc (CRK), and More - Insider Monkey

Aug 23, 2024
pulisher
Aug 23, 2024

Inhibrx stock gains after CEO insider purchase (NASDAQ:INBX-DEFUNCT-599450) - Seeking Alpha

Aug 23, 2024
pulisher
Aug 20, 2024

INBX Stock Earnings: Inhibrx Biosciences Beats EPS for Q2 2024 - MSN

Aug 20, 2024
pulisher
Aug 13, 2024

Home Genius Exteriors® skyrockets into top 35 companies In Qualified Remodeler TOP 500 for 2024 - The Malaysian Reserve

Aug 13, 2024
pulisher
Aug 13, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MCRB, PALT, MRO on Behalf of Shareholders - The Malaysian Reserve

Aug 13, 2024
pulisher
Aug 13, 2024

Specialty Chemicals Market size is set to grow by USD 368.2 billion from 2024-2028, Increasing demand for specialty chemicals from agrochemical industry boost the market, Technavio - The Malaysian Reserve

Aug 13, 2024
pulisher
Aug 13, 2024

Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - Financial Times

Aug 13, 2024
pulisher
Aug 13, 2024

FINBOA Ranks #650 on Inc. 5000 Fastest Growing Companies List - The Malaysian Reserve

Aug 13, 2024
pulisher
Aug 13, 2024

Inhibrx Biosciences Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - PR Newswire

Aug 13, 2024
pulisher
Aug 07, 2024

Inhibrx Biosciences Inc.’s latest rating changes from various analysts - Knox Daily

Aug 07, 2024
pulisher
Aug 07, 2024

(INBX) Investment Report - Stock Traders Daily

Aug 07, 2024
pulisher
Jul 23, 2024

Inhibrx stock rated 'Market Perform' by JMP after Sanofi acquisition - Investing.com

Jul 23, 2024
$358.35
price down icon 0.05%
$21.90
price up icon 4.86%
$224.51
price up icon 2.79%
$66.83
price up icon 1.64%
$118.77
price up icon 0.47%
$542.08
price up icon 1.11%
자본화:     |  볼륨(24시간):